The Secret Of Human Tnfr2/cd120b/tnfrsf1b Protein (tnf-hm3r2) Next Gen [m4ufbjv8]

Human TNFR2/CD120b/TNFRSF1B Protein

Introducing the The Secret Of Human Tnfr2/cd120b/tnfrsf1b Protein (tnf-hm3r2) Next Gen [m4ufbjv8], a high-quality recombinant protein that is meticulously engineered for research purposes. This protein is a crucial component in understanding the immune response and its regulation. With its exceptional purity and stability, it offers reliable results in various experimental settings.

• High Purity: Our TNFR2/CD120b/TNFRSF1B Protein is >95% pure, ensuring accurate and consistent experimental outcomes.
• Stable Formulation: The protein is provided in a stable lyophilized form, making it easy to reconstitute and store.

Product Specifications and Technical Details

The The Secret Of Human Tnfr2/cd120b/tnfrsf1b Protein (tnf-hm3r2) Next Gen [m4ufbjv8] is produced using state-of-the-art biotechnology, offering a high level of specificity and efficacy. It is characterized by its 439 amino acid sequence, with a molecular weight of approximately 50 kDa. This protein plays a vital role in the signaling pathways involved in inflammation and immune regulation.

• Applications: Ideal for use in cell culture, ELISA, Western blot, and immunoprecipitation assays.
• Quality Control: Rigorous quality control measures are implemented throughout the production process to ensure the highest standards of purity and performance.

Practical Applications and Target Audience

The The Secret Of Human Tnfr2/cd120b/tnfrsf1b Protein (tnf-hm3r2) Next Gen [m4ufbjv8] is an invaluable tool for researchers in the fields of immunology, inflammation, and oncology. Its versatile applications make it suitable for various experimental designs, including:

• Immunology Research: Investigating the role of TNFR2 in immune cell signaling and cytokine production.
• Inflammation Studies: Analyzing the impact of TNFR2 activation on inflammatory responses and therapeutic interventions.

This product is particularly beneficial for researchers, medical professionals, and pharmaceutical companies looking to advance their understanding of the immune system and develop new treatments for inflammatory and autoimmune diseases.